UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

Research at UMC Utrecht has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections.

Cell therapy startup’s IPO plans thrown in limbo amid legal spat with investor Alcon

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 12, 2024

Explainer: Labour has been elected in the UK – now what? – Pharmaceutical Technology

The UK Labour Party’s near-landslide victory on 5 July healthcare workers and life science investors have been awaiting Wes Streeting’s next moves. Credit: Shutterstock /

July 12, 2024

Key pressures for SMEs and business outlook in clinical research

There are many challenges small and medium sized businesses must overcome in clinical research. Credit: SFIO CRACHO via Shutterstock. The pharma sector is at a

January 14, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.